Use of self-controlled analytical techniques to assess the association between use of prescription medications and the risk of motor vehicle crashes

American Journal of Epidemiology

Volumn 169, Issue 6, 2009, Pages 761-768

  Gibson, Jack E ^a   Hubbard, Richard B ^a   Smith, Christopher J P ^a   Tata, Laila J ^a   Britton, John R ^a   Fogarty, Andrew W ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Accidents, traffic; Analgesics, opioid; Antidepressive agents, tricyclic; Benzodiazepines; Data interpretation, statistical; Hypnotics and sedatives

Indexed keywords

ANALGESIC AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYPNOTIC AGENT; OPIATE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ACCIDENT; AGE CLASS; ANALYTICAL METHOD; DATABASE; EPIDEMIOLOGY; HEALTH CARE; MEDICINE; OPTIMIZATION; RISK ASSESSMENT; TRAFFIC CONGESTION; TRANSPORT VEHICLE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CASE STUDY; DATA BASE; DRUG USE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; OUTCOME ASSESSMENT; PRESCRIPTION; PRIMARY MEDICAL CARE; RISK ASSESSMENT; STATISTICAL ANALYSIS; TRAFFIC ACCIDENT; TREATMENT DURATION; UNITED KINGDOM;

ACCIDENTS, TRAFFIC; ADOLESCENT; ADULT; AGED; CROSS-OVER STUDIES; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; POISSON DISTRIBUTION; PROSPECTIVE STUDIES; RISK;

EURASIA; EUROPE; UNITED KINGDOM; WESTERN EUROPE;

EID: 61449176182     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwn364     Document Type: Article

References (22)

1. Farrington CP. Control without separate controls: evaluation of vaccine safety using case-only methods. Vaccine. 2004;22(15-16):2064-2070.
2. Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics. 1995;51(1):228-235.
3. Whitaker HJ, Farrington CP, Spiessens B, et al. Tutorial in biostatistics: the self-controlled case series method. Stat Med. 2006;25(10):1768-1797.
4. Thomas RE. Benzodiazepine use and motor vehicle accidents. Systematic review of reported association. Can Fam Physician. 1998;44:799-808.
5. Ramaekers JG. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. J Clin Psychiatry. 2003;64(1):20-29.
6. Seppala T, Linnoila M, Mattila MJ. Drugs, alcohol and driving. Drugs. 1979;17(5):389-408.
7. Weiler JM, Bloomfield JR, Woodworth GG, et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med. 2000;132(5):354-363.
8. Vermeeren A, Riedel WJ, van Boxtel MP, et al. Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. Sleep. 2002;25(2):224-231.
9. Barbone F, McMahon AD, Davey PG, et al. Association of road-traffic accidents with benzodiazepine use. Lancet. 1998;352(9137):1331-1336.
10. Hemmelgarn B, Suissa S, Huang A, et al. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA. 1997;278(1):27-31.
11. Leveille SG, Buchner DM, Koepsell TD, et al. Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology. 1994;5(6):591-598.
12. McGwin G Jr, Sims RV, Pulley L, et al. Relations among chronic medical conditions, medications, and automobile crashes in the elderly: a population-based case-control study. Am J Epidemiol. 2000;152(5):424-431.
13. Neutel CI. Risk of traffic accident injury after a prescription for a benzodiazepine. Ann Epidemiol. 1995;5(3):239-244.
14. Oster G, Huse DM, Adams SF, et al. Benzodiazepine tranquilizers and the risk of accidental injury. Am J Public Health. 1990;80(12):1467-1470.
15. Ray WA, Fought RL, Decker MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol. 1992;136(7):873-883.
16. Hubbard R, Farrington P, Smith C, et al. Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am J Epidemiol. 2003;158(1):77-84.
17. Hubbard R, Lewis S, West J, et al. Bupropion and the risk of sudden death: a self-controlled case-series analysis using The Health Improvement Network. Thorax. 2005;60(10):848-850.
18. Tata LJ, Fortun PJ, Hubbard RB, et al. Does concurrent prescription of selective serotonin reuptake inhibitors and nonsteroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther. 2005;22(3):175-181.
19. Tata LJ, West J, Smith C, et al. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart. 2005;91(4):465-471.
20. Lewis JD, Bilker WB, Weinstein RB, et al. The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf. 2005;14(7):443-451.
21. Musonda P, Farrington CP, Whitaker HJ. Sample sizes for self-controlled case series studies. Stat Med. 2006;25(15):2618-2631.
22. British National Formulary. 54th ed. London, United Kingdom: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2007.